4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-24-000441
Director bought 1,000 shares at an average $12.75 ($12,750)
From the SEC's structured data for this filing
Trades in this filing
Almenoff June Sherie · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-12 | Purchase : show line 1 in the form | +500 | $12.50 | $6,250 | 500 | I |
| 2024-11-13 | Purchase : show line 2 in the form | +500 | $13.00 | $6,500 | 1,000 | I |
| Open-market purchases · 1,000 sh · avg $12.75 · $12,750 | ||||||
Loading xslF345X05/primary_doc.xml…